Mersana Therapeutics, Inc. Comprehensive Income
Mersana Therapeutics, Inc. reported Comprehensive Income of -$7.54 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-11-14
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$7.54M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$24.30M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$24.13M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$14.13M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$69.19M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$171.51M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$204.36M.
- Mersana Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$170.06M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$7.54M 10-Q · filed 2025-11-14 | -$31.84M derived: sum of 2 quarters · filed 2025-11-14 | -$55.97M 10-Q · filed 2025-11-14 | -$70.11M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | -$24.30M 10-Q · filed 2025-08-13 | -$48.43M 10-Q · filed 2025-08-13 | -$62.56M derived: sum of 3 quarters · filed 2025-08-13 | -$73.97M derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-03-31 | -$24.13M 10-Q · filed 2025-05-15 | -$38.27M derived: sum of 2 quarters · filed 2025-05-15 | -$49.67M derived: sum of 3 quarters · filed 2025-11-14 | -$73.92M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-12-31 | -$14.13M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$25.54M derived: sum of 2 quarters · filed 2025-11-14 | -$49.79M derived: sum of 3 quarters · filed 2025-11-14 | -$69.19M 10-K · filed 2025-03-03 |
| 2024-09-30 | -$11.40M 10-Q · filed 2025-11-14 | -$35.65M derived: sum of 2 quarters · filed 2025-11-14 | -$55.06M 10-Q · filed 2025-11-14 | -$74.59M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$24.25M 10-Q · filed 2025-08-13 | -$43.66M 10-Q · filed 2025-08-13 | -$63.19M derived: sum of 3 quarters · filed 2025-08-13 | -$104.80M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$19.41M 10-Q · filed 2025-05-15 | -$38.94M derived: sum of 2 quarters · filed 2025-05-15 | -$80.55M derived: sum of 3 quarters · filed 2025-05-15 | -$134.91M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$19.53M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$61.14M derived: sum of 2 quarters · filed 2025-03-03 | -$115.51M derived: sum of 3 quarters · filed 2025-03-03 | -$171.51M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$41.61M 10-Q · filed 2024-11-13 | -$95.97M derived: sum of 2 quarters · filed 2024-11-13 | -$151.97M 10-Q · filed 2024-11-13 | -$196.82M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$54.37M 10-Q · filed 2024-08-13 | -$110.37M 10-Q · filed 2024-08-13 | -$155.21M derived: sum of 3 quarters · filed 2025-03-03 | -$215.13M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$56.00M 10-Q · filed 2024-05-09 | -$100.84M derived: sum of 2 quarters · filed 2025-03-03 | -$160.76M derived: sum of 3 quarters · filed 2025-03-03 | -$213.10M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$44.84M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$104.76M derived: sum of 2 quarters · filed 2025-03-03 | -$157.11M derived: sum of 3 quarters · filed 2025-03-03 | -$204.36M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$59.92M 10-Q · filed 2023-11-07 | -$112.26M derived: sum of 2 quarters · filed 2023-11-07 | -$159.52M 10-Q · filed 2023-11-07 | -$208.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$52.34M 10-Q · filed 2023-08-08 | -$99.60M 10-Q · filed 2023-08-08 | -$148.59M derived: sum of 3 quarters · filed 2024-02-28 | -$194.06M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$47.26M 10-Q · filed 2023-05-09 | -$96.24M derived: sum of 2 quarters · filed 2024-02-28 | -$141.71M derived: sum of 3 quarters · filed 2024-02-28 | -$182.63M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$48.98M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$94.45M derived: sum of 2 quarters · filed 2024-02-28 | -$135.37M derived: sum of 3 quarters · filed 2024-02-28 | -$170.06M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$45.47M 10-Q · filed 2022-11-07 | -$86.38M derived: sum of 2 quarters · filed 2022-11-07 | -$121.08M 10-Q · filed 2022-11-07 | -$149.92M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$40.91M 10-Q · filed 2022-08-08 | -$75.61M 10-Q · filed 2022-08-08 | -$104.45M derived: sum of 3 quarters · filed 2023-02-28 | -$126.94M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$34.69M 10-Q · filed 2021-05-10 | -$63.53M derived: sum of 2 quarters · filed 2023-02-28 | -$86.03M derived: sum of 3 quarters · filed 2023-02-28 | -$105.81M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$28.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$51.33M derived: sum of 2 quarters · filed 2023-02-28 | -$71.11M derived: sum of 3 quarters · filed 2023-02-28 | -$88.07M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$22.49M 10-Q · filed 2021-11-09 | -$42.27M derived: sum of 2 quarters · filed 2021-11-09 | -$59.23M 10-Q · filed 2021-11-09 | -$75.47M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$19.78M 10-Q · filed 2021-08-06 | -$36.73M 10-Q · filed 2021-08-06 | -$52.98M derived: sum of 3 quarters · filed 2022-02-28 | -$69.76M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$16.95M 10-Q · filed 2021-05-10 | -$33.20M derived: sum of 2 quarters · filed 2022-02-28 | -$49.98M derived: sum of 3 quarters · filed 2022-02-28 | -$67.04M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$16.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$33.02M derived: sum of 2 quarters · filed 2022-02-28 | -$50.08M derived: sum of 3 quarters · filed 2022-02-28 | -$28.18M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$16.77M 10-Q · filed 2020-11-09 | -$33.84M derived: sum of 2 quarters · filed 2020-11-09 | -$11.93M 10-Q · filed 2020-11-09 | -$34.32M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$17.06M 10-Q · filed 2020-08-07 | $4.85M 10-Q · filed 2020-08-07 | -$17.55M derived: sum of 3 quarters · filed 2021-02-26 | -$34.57M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $21.91M 10-Q · filed 2020-05-08 | -$489.00K derived: sum of 2 quarters · filed 2021-02-26 | -$17.51M derived: sum of 3 quarters · filed 2021-02-26 | -$29.79M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | -$22.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$39.42M derived: sum of 2 quarters · filed 2021-02-26 | -$51.70M derived: sum of 3 quarters · filed 2021-02-26 | -$64.12M 10-K · filed 2021-02-26 |
| 2018-09-30 | -$17.02M 10-Q · filed 2019-11-06 | -$29.30M derived: sum of 2 quarters · filed 2019-11-06 | -$41.72M 10-Q · filed 2019-11-06 | -$55.82M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | -$12.28M 10-Q · filed 2019-08-08 | -$24.70M 10-Q · filed 2019-08-08 | -$38.80M derived: sum of 3 quarters · filed 2020-02-28 | -$46.54M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | -$12.42M 10-Q · filed 2019-05-09 | -$26.52M derived: sum of 2 quarters · filed 2020-02-28 | -$34.26M derived: sum of 3 quarters · filed 2020-02-28 | -$43.21M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$14.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$21.84M derived: sum of 2 quarters · filed 2020-02-28 | -$30.79M derived: sum of 3 quarters · filed 2020-02-28 | -$38.86M 10-K · filed 2020-02-28 |
| 2017-09-30 | -$7.74M 10-Q · filed 2018-11-13 | -$16.69M derived: sum of 2 quarters · filed 2018-11-13 | -$24.75M 10-Q · filed 2018-11-13 | -$23.50M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-06-30 | -$8.96M 10-Q · filed 2018-08-14 | -$17.02M 10-Q · filed 2018-08-14 | -$15.76M derived: sum of 3 quarters · filed 2019-03-08 | -$21.59M derived: sum of 4 quarters · filed 2019-03-08 |
| 2017-03-31 | -$8.06M 10-Q · filed 2018-05-15 | -$6.80M derived: sum of 2 quarters · filed 2019-03-08 | -$12.64M derived: sum of 3 quarters · filed 2019-03-08 | -$16.41M derived: sum of 4 quarters · filed 2019-03-08 |
| 2016-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-08 | -$4.58M derived: sum of 2 quarters · filed 2019-03-08 | -$8.34M derived: sum of 3 quarters · filed 2019-03-08 | -$13.70M 10-K · filed 2019-03-08 |
| 2016-09-30 | -$5.84M 10-Q · filed 2017-11-13 | -$9.60M derived: sum of 2 quarters · filed 2017-11-13 | -$14.96M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$3.77M 10-Q · filed 2017-08-11 | -$9.12M 10-Q · filed 2017-08-11 | ||
| 2015-12-31 | -$16.43M 10-K · filed 2018-03-28 |